NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 937 filers reported holding NOVARTIS A G in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $296,000 | -22.5% | 3,590 | -31.9% | 0.10% | -23.4% |
| Q1 2016 | $382,000 | -39.8% | 5,275 | -28.5% | 0.12% | -37.4% |
| Q4 2015 | $635,000 | -15.1% | 7,375 | -9.4% | 0.20% | -18.5% |
| Q3 2015 | $748,000 | -11.2% | 8,140 | -5.0% | 0.24% | -7.6% |
| Q2 2015 | $842,000 | +5.9% | 8,565 | +6.2% | 0.26% | -2.2% |
| Q1 2015 | $795,000 | +93.9% | 8,065 | +82.3% | 0.27% | +60.1% |
| Q4 2014 | $410,000 | -2.1% | 4,425 | -0.6% | 0.17% | -5.6% |
| Q3 2014 | $419,000 | -4.1% | 4,450 | -7.8% | 0.18% | -6.8% |
| Q2 2014 | $437,000 | -20.3% | 4,825 | -25.2% | 0.19% | -18.4% |
| Q1 2014 | $548,000 | -0.5% | 6,450 | -5.8% | 0.23% | -3.7% |
| Q4 2013 | $551,000 | -7.9% | 6,850 | -12.2% | 0.24% | -16.5% |
| Q3 2013 | $598,000 | +15.9% | 7,800 | +6.8% | 0.29% | +17.8% |
| Q2 2013 | $516,000 | – | 7,300 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |